The Sexual Ethics of HPV Vaccination for Boys

Abstract

Human papillomavirus (HPV) is one of the most common sexually transmitted infections. It is a leading cause of cervical cancer in women but the virus is increasingly being linked to several other cancers in men and women alike. Since the introduction of safe and effective but also expensive vaccines, many developed countries have implemented selective vaccination programs for girls. Some however argue that these programs should be expanded to include boys, since (1) HPV constitutes non-negligible health risks for boys as well and (2) protected boys will indirectly also protect girls. In this paper we approach this discussion from an ethical perspective. First, on which moral grounds can one justify not reimbursing vaccination for the male sex? We develop an ethical framework to evaluate selective vaccination programs and conclude that, in the case of HPV, efficiency needs to be balanced against non-stigmatization, non-discrimination and justice. Second, if vaccination programs were to be expanded to boys as well, do the latter then also have a moral duty to become immunized? Two arguments in favor of such a moral duty are well known in vaccination ethics: the duty not to harm others and to contribute to the public good of public health. However, we argue that these are not particularly convincing in the context of HPV. In contrast, we believe a third, more powerful but also more controversial argument is possible. In our view, the sexual mode of transmission of HPV constitutes an additional reason to believe that boys in fact may have a moral obligation to accept vaccination.

This is a preview of subscription content, log in to check access.

Notes

  1. 1.

    The term ‘discrimination’ appears to have two different uses. Although it is sometimes used to denote any form of differentiation between individuals, we want to focus only on illegitimate, unjust or prejudiced forms of discrimination, which arise when individuals are given differential treatment on the basis of characteristics that are not relevant to the case at hand.

  2. 2.

    In the remainder of the paper we will speak of boys’ moral duty to become vaccinated against HPV, even though their parents are to accept vaccination given that the vaccine would be offered in their early teens. We thus speak of boys’ duty to accept vaccination as shorthand for the parents’ duty to accept vaccination for their sons on behalf of their sons.

  3. 3.

    Given the fact that HPV vaccination is most effective before one’s sexual debut and is thus best administered in children’s early teens, this concern for health is to be framed in terms of the parents’ moral duties towards their children. In fact, arguing that individuals have the moral duty to promote their own health may be more controversial than arguing that parents have the moral duty to take care of their children’s health (Archard and Benatar 2010).

  4. 4.

    Whereas the usefulness of sex for the continuation of humanity is obvious, this is in itself no judgment regarding the desirability of humanity and societies continuing to exist. A case against the latter can be found in Benatar (2006).

References

  1. Achkar, J. M., & Macklin, R. (2009). Ethical considerations about reporting research results with potential for further stigmatization of undocumented immigrants. Clinical Infectious Diseases, 48(9), 1250–1253. doi:10.1086/597587.

    Article  Google Scholar 

  2. Ali, H., Guy, R. J., Wand, H., Read, T. R., Regan, D. G., Grulich, A. E., Fairley, C. K., Donovan, B. (2013). Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infectious Disease, 13, 140. doi:10.1186/1471-2334-13-140.

  3. Arbyn, M., Castellsague, X., de Sanjose, S., Bruni, L., Saraiya, M., Bray, F., et al. (2011). Worldwide burden of cervical cancer in 2008. Annals of Oncology, 22(12), 2675–2686. doi:10.1093/annonc/mdr015.

    Article  Google Scholar 

  4. Archard, D., & Benatar, D. E. (2010). Procreation and parenthood: The ethics of bearing and rearing children. Oxford: Oxford University Press.

    Google Scholar 

  5. Barroso, L. F., I. I., & Wilkin, T. (2011). Human papillomavirus vaccination in males: The state of the science. Current Infectious Disease Reports, 13(2), 175–181. doi:10.1007/s11908-010-0163-7.

    Article  Google Scholar 

  6. Beauchamp, T., & Childress, J. (2001). Principles of biomedical ethics (5th ed.). Oxford: Oxford University Press.

    Google Scholar 

  7. Benatar, D. (2006). Better never to have been: The harm of coming into existence. Oxford: Oxford University Press.

    Google Scholar 

  8. Beutels, P. (2001). Economic evaluations of hepatitis B immunization: A global review of recent studies (1994–2000). Health Economics, 10(8), 751–774. doi:10.1002/hec.625.

    Article  Google Scholar 

  9. Beutels, P., & Jit, M. (2010). A brief history of economic evaluation for human papillomavirus vaccination policy. Sex Health, 7(3), 352–358. doi:10.1071/SH10018.

    Article  Google Scholar 

  10. Beutels, P., Scuffham, P. A., & MacIntyre, C. R. (2008). Funding of drugs: Do vaccines warrant a different approach? The Lancet Infectious Disease, 8(11), 727–733. doi:10.1016/S1473-3099(08)70258-5.

    Google Scholar 

  11. Brankovic, I., Verdonk, P., & Klinge, I. (2013). Applying a gender lens on human papillomavirus infection: Cervical cancer screening, HPV DNA testing, and HPV vaccination. International Journal for Equity in Health, 12, 14. doi:10.1186/1475-9276-12-14.

    Article  Google Scholar 

  12. Brisson, M., van de Velde, N., Franco, E. L., Drolet, M., & Boily, M. C. (2011). Incremental impact of adding boys to current human papillomavirus vaccination programs: Role of herd immunity. Journal of Infectious Diseases, 204(3), 372–376. doi:10.1093/infdis/jir285.

    Article  Google Scholar 

  13. Burls, A., Jordan, R., Barton, P., Olowokure, B., Wake, B., Albon, E., et al. (2006). Vaccinating healthcare workers against influenza to protect the vulnerable—Is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation. Vaccine, 24(19), 4212–4221. doi:10.1016/j.vaccine.2005.12.043.

    Article  Google Scholar 

  14. Chaturvedi, A. K. (2010). Beyond cervical cancer: burden of other HPV-related cancers among men and women. Journal of Adolescent Health, 46(4 Suppl), S20–S26. doi:10.1016/j.jadohealth.2010.01.016.

    Article  Google Scholar 

  15. Daniels, N., Kennedy, B., & Kawachi, I. (2000). justice Is good for our health: How greater economic equality would promote public health. Boston Review, 25(1), 4–19.

    Google Scholar 

  16. Dawson, A. (2007). What are the moral obligations of the traveller in relation to vaccination? Travel Medicine and Infectious Disease, 5(2), 90–96. doi:10.1016/j.tmaid.2006.01.005.

    Article  Google Scholar 

  17. Dawson, A. (2009). Herd protection as a public good: Vaccination and our obligations to others. In A. Dawson & M. Verweij (Eds.), Ethics, prevention and public health. Oxford: Oxford University Press.

    Google Scholar 

  18. Doorbar, J., Quint, W., Banks, L., Bravo, I. G., Stoler, M., Broker, T. R., et al. (2012). The biology and life-cycle of human papillomaviruses. Vaccine, 30(Suppl 5), F55–F70. doi:10.1016/j.vaccine.2012.06.083.

    Article  Google Scholar 

  19. Ed. (2013). GAVI injects new life into HPV vaccine rollout. The Lancet, 381(9879), 1688.

    Google Scholar 

  20. Fine, P., Eames, K., & Heymann, D. L. (2011). “Herd immunity”: A rough guide. Clinical Infectious Diseases, 52(7), 911–916. doi:10.1093/cid/cir007.

    Article  Google Scholar 

  21. Gautret, P., Yong, W., Soula, G., Parola, P., Brouqui, P., & DelVecchio Good, M. J. (2010). Determinants of tetanus, diphtheria and poliomyelitis vaccinations among Hajj pilgrims, Marseille, France. European Journal of Public Health, 20(4), 438–442. doi:10.1093/eurpub/ckp196.

    Article  Google Scholar 

  22. Gillison, M. L., & Shah, K. V. (2003). Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. National Cancer Institute Monographs, 31, 57–65.

    Article  Google Scholar 

  23. Harris, J., & Holm, S. (1995). Is there a moral obligation not to infect others? BMJ, 311(7014), 1215–1217.

    Article  Google Scholar 

  24. Hinman, A. R. (2004). Immunization, equity, and human rights. American Journal of Preventive Medicine, 26(1), 84–88.

    Article  Google Scholar 

  25. Judd, A., Hickman, M., Hope, V. D., Sutton, A. J., Stimson, G. V., Ramsay, M. E., Gill, O. N., Parry, J. V. (2007). Twenty years of selective hepatitis B vaccination: Is hepatitis B declining among injecting drug users in England and Wales? Journal of Viral Hepatitis, 14(8), 584–591. doi:10.1111/j.1365-2893.2007.00844.x.

    Google Scholar 

  26. Kim, J. J., Andres-Beck, B., & Goldie, S. J. (2007). The value of including boys in an HPV vaccination programme: A cost-effectiveness analysis in a low-resource setting. British Journal of Cancer, 97(9), 1322–1328. doi:10.1038/sj.bjc.6604023.

    Article  Google Scholar 

  27. Kirby, T. (2012). Australia to be first country to vaccinate boys against HPV. Lancet Oncology, 13(8), e333.

    Article  Google Scholar 

  28. Kolf, C. (2012). QnAs with Harald zur Hausen [Biography Historical Article Interview]. Proceedings of the National Academy of Sciences of the United States of America, 109(5), 1378. doi:10.1073/pnas.1120821109.

    Article  Google Scholar 

  29. Kubba, T. (2008). Human papillomavirus vaccination in the United Kingdom: What about boys? Reproductive Health Matters, 16(32), 97–103. doi:10.1016/S0968-8080(08)32413-6.

    Article  Google Scholar 

  30. Lefevere, E., Hens, N., Theeten, H., Van den Bosch, K., Beutels, P., De Smet, F., et al. (2011). Like mother, like daughter? Mother’s history of cervical cancer screening and daughter’s Human Papillomavirus vaccine uptake in Flanders (Belgium). Vaccine, 29(46), 8390–8396. doi:10.1016/j.vaccine.2011.08.039.

    Article  Google Scholar 

  31. Luyten, J., Dorgali, V., Hens, N., & Beutels, P. (2013). Public preferences over efficiency, equity and autonomy in vaccination policy: An empirical study. Social Science and Medicine, 77, 84–89. doi:10.1016/j.socscimed.2012.11.009.

    Article  Google Scholar 

  32. Luyten, J., Vandevelde, A., Van Damme, P., & Beutels, P. (2011). Vaccination policy and ethical challenges posed by herd immunity, suboptimal uptake and subgroup targeting. Public Health Ethics, 4(3), 280–291. doi:10.1093/Phe/Phr032.

    Article  Google Scholar 

  33. Machalek, D. A., Grulich, A. E., Jin, F., Templeton, D. J., & Poynten, I. M. (2012). The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men. Sex Health, 9(6), 527–537. doi:10.1071/SH12043.

    Article  Google Scholar 

  34. Malmqvist, E., Helgesson, G., Lehtinen, J., Natunen, K., & Lehtinen, M. (2011). The ethics of implementing human papillomavirus vaccination in developed countries. Medicine, Health Care and Philosophy, 14(1), 19–27. doi:10.1007/s11019-010-9285-9.

    Article  Google Scholar 

  35. Malmqvist, E., Natunen, K., Lehtinen, M., & Helgesson, G. (2012). Just implementation of human papillomavirus vaccination. Journal of Medical Ethics, 38(4), 247–249. doi:10.1136/medethics-2011-100090.

    Article  Google Scholar 

  36. Manhart, L. E., & Koutsky, L. A. (2002). Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sexually Transmitted Diseases, 29(11), 725–735.

    Article  Google Scholar 

  37. Marra, F., Cloutier, K., Oteng, B., Marra, C., & Ogilvie, G. (2009). Effectiveness and cost effectiveness of human papillomavirus vaccine: A systematic review. Pharmacoeconomics, 27(2), 127–147. doi:10.2165/00019053-200927020-00004. 4 [pii].

    Article  Google Scholar 

  38. Mill, J. S. (1869). On liberty. London: Longman, Roberts & Green.

    Google Scholar 

  39. Munoz, N., Bosch, F. X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K. V.,Snijders, P. J., & Meijer, C. J. (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. The New England Journal of Medicine, 348(6), 518–527. doi:10.1056/NEJMoa021641.

  40. Newall, A. T., Beutels, P., Wood, J. G., Edmunds, W. J., & MacIntyre, C. R. (2007). Cost-effectiveness analyses of human papillomavirus vaccination. The Lancet Infectious Disease, 7(4), 289–296. doi:10.1016/S1473-3099(07)70083-X.

    Article  Google Scholar 

  41. Parkin, D. M., & Bray, F. (2006). Chapter 2: The burden of HPV-related cancers. Vaccine, 24(Suppl 3), S3/11–S3/25. doi:10.1016/j.vaccine.2006.05.111.

  42. Postma, M. J., Bos, J. M., Beutels, P., Schilthuis, H., & van den Hoek, J. A. (2004). Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands). Vaccine, 22(15–16), 1862–1867. doi:10.1016/j.vaccine.2003.11.012.

    Article  Google Scholar 

  43. Salo, H., Leino, T., Kilpi, T., Auranen, K., Tiihonen, P., Lehtinen, M.,…,Nieminen, P. (2013). The burden and costs of prevention and management of genital disease caused by HPV in women: A population-based registry study in Finland. International Journal of Cancer. doi:10.1002/ijc.28145.

  44. Schiller, J. T., Castellsague, X., & Garland, S. M. (2012). A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine, 30(Suppl 5), F123–F138. doi:10.1016/j.vaccine.2012.04.108.

    Article  Google Scholar 

  45. Slote, M. (2000). Virtue ethics. In H. Lafollette (Ed.), The Blackwell guide to ethical theory (pp. 325–347). Malden, MA: Blackwell.

    Google Scholar 

  46. Thaler, R. H., & Sunstein, C. (2008). Nudge: Improving decisions about health, wealth and happiness. New Haven, NJ: Yale University Press.

    Google Scholar 

  47. Trottier, H., & Burchell, A. N. (2009). Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics, 12(5–6), 291–307. doi:10.1159/000214920.

    Article  Google Scholar 

  48. Wellman, C. (2001). Toward a liberal theory of political obligation. Ethics, 111(4), 735–759.

    Article  Google Scholar 

  49. Whitley, R. J., & Roizman, B. (2001). Herpes simplex virus infections. The Lancet, 357(9267), 1513–1518. doi:10.1016/S0140-6736(00)04638-9.

  50. Wu, X., Watson, M., Wilson, R., Saraiya, M., Cleveland, J., & Markowitz, L. (2012). Human papillomavirus-associated cancers—United States, 2004–2008. Morbidity and Mortality Weekly Report of Centers for Disease Control and Prevention, 61(15), 258–261.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Jeroen Luyten.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Luyten, J., Engelen, B. & Beutels, P. The Sexual Ethics of HPV Vaccination for Boys. HEC Forum 26, 27–42 (2014). https://doi.org/10.1007/s10730-013-9219-z

Download citation

Keywords

  • Infectious disease
  • Public health
  • Immunization
  • Efficiency
  • Sexually transmitted infection
  • HPV